Dr. Robert F. Waters is an Adjunct Research Professor at the Biodesign Institute for Infectious Diseases and Vaccinology at Arizona State University (ASU), USA. He is a multidisciplinary researcher with extensive contributions to genetics, biochemical pathways, immunomodulatory botanicals, and antiviral drug discovery. Dr. Waters has authored numerous peer-reviewed publications and has conducted herbogenomic investigations, including studies on inflammatory gene regulation (GEO Series: GSE19128).

He has taught a wide range of graduate and professional courses in Medical Biochemistry, Medical Genetics, Biostatistics, and Medical Research, and has supervised more than 135 graduate research projects. Trained in both biochemical genetics and computer science, Dr. Waters has also developed medical and emergency-response software systems and serves as a consultant to global biotechnology and healthcare organizations. He holds a PhD in Biochemical Genetics from Montana State University and is a member of the College of Medical Genetics.

Research area: Infectious diseases, Vaccinology, Immunostimulatory botanicals, Herbogenomics, Antiviral research, Inflammatory, gene expression, Medical biochemistry, Medical genetics, Biochemical genetics, Microarray analysis, PBMC gene expression, Botanical medicine, Amino acid research, Computational biology

Dr. Dino Prato, NMD, is the Founder and CEO of Envita Medical Centers, Envita Health, and Envita Interventional Radiology Oncology. For over 25 years, he has led the development of precision, integrative medical treatments for late-stage cancers and complex chronic diseases. A graduate of Southwest College of Naturopathic Medicine and Grand Canyon University, Dr. Prato is recognized for pioneering genomics-driven, N-of-1 treatment design and novel immunotherapy targets. Under his leadership, Envita employs more than 160 medical professionals dedicated to advancing personalized, research-based care. His mission centers on transforming healthcare and improving human life through precision medicine.

Research area: precision oncology; integrative medicine; personalized cancer therapy; genomics-based treatment; N-of-1 medicine; chronic disease management; immunotherapy targets; interventional oncology; naturopathic oncology; molecular diagnostics; Lyme disease research; advanced cancer care.

Dr. Jonathan V. Wright, M.D., Medical Director of Tahoma Clinic, is a pioneering figure in nutritional and natural medicine. A graduate of Harvard University and the University of Michigan Medical School, he has spent over four decades advancing bioidentical hormone therapy, nutritional therapeutics, and non-drug treatment strategies. Since 1976, he has compiled an extensive research archive on diet, vitamins, minerals, botanicals, and natural substances, forming the basis of numerous clinical innovations. Dr. Wright has trained thousands of physicians worldwide and authored 13 widely read books. His work continues to shape modern integrative medicine and patient-centered, natural therapeutic care.

Research area: Bioidentical hormone therapy; integrative medicine; nutritional therapeutics; natural treatments; botanical medicine; anti-aging medicine; non-drug therapies; D-mannose research; iodine metabolism; macular degeneration treatment; asthma natural therapy; orthomolecular medicine; holistic healthcare; Tahoma Clinic.

Dr. Michael Verlander is an accomplished pharmaceutical consultant specializing in product development, quality assurance, and regulatory compliance. He currently serves on USP’s Biologics Monographs-1 Peptides and Oligonucleotides Expert Committee and the Glatiramer Acetate Expert Panel. With decades of leadership in peptide API manufacturing, he has held senior roles at the PolyPeptide Group, including President of PolyPeptide Laboratories San Diego and Global Director of Quality Assurance and Regulatory Affairs. His career also includes pivotal positions at Bachem California and extensive contributions to peptide research at Immunetech Pharmaceuticals, BioResearch Inc., and the University of California, San Diego.

Research area: Peptide therapeutics; pharmaceutical quality assurance; regulatory affairs; peptide APIs; USP expert committee; oligonucleotides; biologics standards; drug development; PolyPeptide Group; Bachem California; peptide research; biotechnology leadership; GMP compliance.